Leveraging existing mid‐end ultrasound machine for point‐of‐care intestinal ultrasound in low‐resource settings: Prospective, real‐world impact on clinical decision‐making
Alimentary Pharmacology & Therapeutics · 2024
DOI: 10.1111/apt.18155 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alimentary Pharmacology & Therapeutics, 2024. Verfasst von Partha Pal und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Gastroenterology, Asian Institute of Gastroenterology, Hyderabad, India. Hauptthemen laut MEDLINE: Ultrasonography, Clinical Decision-Making, Point-of-Care Systems, Leukocyte L1 Antigen Complex. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
Background
Point‐of‐care ultrasound (POCUS) has transformed inflammatory bowel disease (IBD) management, but the cost to purchase high‐end equipment can be prohibitive.
Aim
To assess prospectively the feasibility of POCUS using pre‐existing mid‐end ultrasound equipment without incurring additional cost.
Methods
Consecutive IBD patients underwent POCUS with or without faecal calprotectin (FCP) using a mid‐end ultrasound machine. If POCUS with or without FCP could not guide management, we performed additional ileocolonoscopy or cross‐sectional imaging. We evaluated the impact of POCUS on IBD management and its correlation with ileocolonoscopy or cross‐sectional imaging. We analysed pregnant, paediatric and post‐operative patients separately.
Results
Among 508 patients with IBD, we analysed 419 (60.4% Crohn's disease [CD]; 61.3% male, age [years]: 36 [18–78]) undergoing 556 POCUS sessions. POCUS with or without FCP independently influenced clinical management in 42.8% of patients with CD and 49.7% with ulcerative colitis (UC). POCUS helped avoid colonoscopy in 51.4% of patients with CD and 51.8% with UC, and cross‐sectional imaging in 38.1% of suspected active small bowel CD. In patients with additional diagnostics, POCUS‐based decisions remained unchanged in 81.2% with CD and 85% with UC. Sensitivity and specificity of POCUS compared to ileocolonoscopy were 80% and 94.4% for CD and 80.8% and 92.8% for UC, respectively. Sensitivity and specificity compared to cross‐sectional imaging were 87.2% and 87.5%, respectively.
Conclusion
POCUS using existing mid‐end ultrasound equipment in low‐resource settings influenced IBD clinical decision‐making with excellent accuracy, often avoiding colonoscopy and cross‐sectional imaging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Gastroenterology, Asian Institute of Gastroenterology, Hyderabad, India.
- Department of Diagnostic Radiology and Ultrasound, Asian Institute of Gastroenterology, Hyderabad, India.
- Department of Interventional Radiology, Asian Institute of Gastroenterology, Hyderabad, India.
ORCID-Profile: Partha Pal
Zitieren
APA
Pal, P., Mateen, M. A., Pooja, K., Marri, U. K., Gupta, R., Tandan, M., & Reddy, D. N. (2024). Leveraging existing mid‐end ultrasound machine for point‐of‐care intestinal ultrasound in low‐resource settings: Prospective, real‐world impact on clinical decision‐making. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.18155
Vancouver
Pal P, Mateen MA, Pooja K, Marri UK, Gupta R, Tandan M, et al. Leveraging existing mid‐end ultrasound machine for point‐of‐care intestinal ultrasound in low‐resource settings: Prospective, real‐world impact on clinical decision‐making. Alimentary Pharmacology & Therapeutics. 2024. doi:10.1111/apt.18155
BibTeX
@article{Pal2024,
author = {Pal, Partha and Mateen, Mohammad Abdul and Pooja, Kanapuram and Marri, Uday Kumar and Gupta, Rajesh and Tandan, Manu and Reddy, D Nageshwar},
title = {Leveraging existing mid‐end ultrasound machine for point‐of‐care intestinal ultrasound in low‐resource settings: Prospective, real‐world impact on clinical decision‐making},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2024},
doi = {10.1111/apt.18155}
}
EUVIMED